The antiinfective medicine sales in Italy are expected to experience a gradual decline from 10.2% of total pharmaceutical sales in 2024 to 9.6% by 2028. This forecast indicates a consistent decrease over the five-year period. Key factors contributing to this downward trend may include advancements in healthcare leading to more targeted therapies, potential market saturation, and a shift towards preventive measures.

Future trends to watch for in the antiinfective market include:

Increased focus on antibiotic resistance and developing new classes of antibiotics.
Emergence of personalized medicine tailoring treatments to individual patient profiles.
Rising investments in biotechnology aimed at discovering novel antiinfective treatments.